CAS NO: | 899821-23-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | ACP-105 is an orally available, selective amd potentandrogen receptormodulator (SARM), withpEC50sof 9.0 and 9.3 for AR wild type and T877A mutant, respectively. | ||||||||||||||||
IC50& Target | pEC50: 9.0 (AR wild type), 9.3 (AR T877A mutant)[1]. | ||||||||||||||||
体外研究 (In Vitro) | ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. The half-lives of ACP-105 (compound 1) in human hepatocytes is measured and found to be 5.0 h[1]. | ||||||||||||||||
体内研究 (In Vivo) | ACP-105 enhances freezing in both sham-irradiated and irradiated mice (effect of ACP-105: F=5.44; p=0.028). For MAP-2 immunoreactivity in the cortex of sham-irradiated mice, there is a brain area×ACP-105 interaction (F=6.655; p=0.0027). While ACP-105 reduces MAP-2 immunoreactivity in the sensorymotor cortex, there is a trend towards increased MAP-2 immunoreactivity in the enthorhinal cortex[2]. | ||||||||||||||||
分子量 | 290.79 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H19ClN2O | ||||||||||||||||
CAS 号 | 899821-23-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 103 mg/mL(354.21 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |